×
About 644 results

ALLMedicine™ Erysipelas Center

Research & Reviews  291 results

Burden, risk factors and infectious complications of cellulitis and erysipelas in Unite...
https://doi.org/10.1016/j.jaad.2020.11.021
Journal of the American Academy of Dermatology; Ren Z, Silverberg JI

Nov 25th, 2020 - Little is known about the utilization and burden of emergency department (ED) visits for cellulitis/erysipelas in the United States. To determine the prevalence, risk factors, complications and cost of emergency care for cellulitis/erysipelas in t...

Erysipelas-like erythema in children with familial Mediterranean fever.
https://www.ncbi.nlm.nih.gov/pubmed/33124556
Clinical and Experimental Rheumatology; Gezgin Yildirim D, Seven MB et. al.

Oct 30th, 2020 - Erysipelas-like erythema (ELE) is a well-known pathognomonic skin lesion associated with familial Mediterranean fever (FMF). The aim of this study was to describe the clinical and demographic features and phenotypic differences between paediatric ...

Long-term risk of dementia following hospitalization due to physical diseases: A multic...
https://doi.org/10.1002/alz.12167
Alzheimer's & Dementia : the Journal of the Alzheimer's Association REFERENCES; Sipilä PN, Lindbohm JV et. al.

Sep 4th, 2020 - Conventional risk factors targeted by prevention (e.g., low education, smoking, and obesity) are associated with a 1.2- to 2-fold increased risk of dementia. It is unclear whether having a physical disease is an equally important risk factor for d...

Current trends in the real-life use of dalbavancin: report of a study panel.
https://doi.org/10.1016/j.ijantimicag.2020.106107
International Journal of Antimicrobial Agents; Durante-Mangoni E, Gambardella M et. al.

Jul 29th, 2020 - Dalbavancin is a novel lipoglycopeptide antibiotic with a chemical structure similar to teicoplanin. Dalbavancin has been approved and marketed since 2014 in the USA and 2015 in the European Union for the treatment of acute bacterial skin and skin...

Erysipelas Medication
https://emedicine.medscape.com/article/1052445-medication

Jun 18th, 2020 - Medication Summary Antibiotics should be started as soon as possible in patients with erysipelas. As previously stated, streptococci cause most cases of the disease; thus, penicillin has remained a first-line therapy. [17, 18] A first-generation c...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  323 results

Burden, risk factors and infectious complications of cellulitis and erysipelas in Unite...
https://doi.org/10.1016/j.jaad.2020.11.021
Journal of the American Academy of Dermatology; Ren Z, Silverberg JI

Nov 25th, 2020 - Little is known about the utilization and burden of emergency department (ED) visits for cellulitis/erysipelas in the United States. To determine the prevalence, risk factors, complications and cost of emergency care for cellulitis/erysipelas in t...

Erysipelas-like erythema in children with familial Mediterranean fever.
https://www.ncbi.nlm.nih.gov/pubmed/33124556
Clinical and Experimental Rheumatology; Gezgin Yildirim D, Seven MB et. al.

Oct 30th, 2020 - Erysipelas-like erythema (ELE) is a well-known pathognomonic skin lesion associated with familial Mediterranean fever (FMF). The aim of this study was to describe the clinical and demographic features and phenotypic differences between paediatric ...

Long-term risk of dementia following hospitalization due to physical diseases: A multic...
https://doi.org/10.1002/alz.12167
Alzheimer's & Dementia : the Journal of the Alzheimer's Association REFERENCES; Sipilä PN, Lindbohm JV et. al.

Sep 4th, 2020 - Conventional risk factors targeted by prevention (e.g., low education, smoking, and obesity) are associated with a 1.2- to 2-fold increased risk of dementia. It is unclear whether having a physical disease is an equally important risk factor for d...

Current trends in the real-life use of dalbavancin: report of a study panel.
https://doi.org/10.1016/j.ijantimicag.2020.106107
International Journal of Antimicrobial Agents; Durante-Mangoni E, Gambardella M et. al.

Jul 29th, 2020 - Dalbavancin is a novel lipoglycopeptide antibiotic with a chemical structure similar to teicoplanin. Dalbavancin has been approved and marketed since 2014 in the USA and 2015 in the European Union for the treatment of acute bacterial skin and skin...

Erysipelas Medication
https://emedicine.medscape.com/article/1052445-medication

Jun 18th, 2020 - Medication Summary Antibiotics should be started as soon as possible in patients with erysipelas. As previously stated, streptococci cause most cases of the disease; thus, penicillin has remained a first-line therapy. [17, 18] A first-generation c...

see more →

News  11 results

Infection Rates Rise in RA After Joint Surgery
https://www.medpagetoday.com/surgery/orthopedics/80577

Jun 19th, 2019 - Patients with rheumatoid arthritis (RA) had an increased risk of nonsurgical site infection but a lower risk for venous thromboembolism (VTE) following joint replacement surgery, a nationwide Danish study found. Compared with patients with osteoar...

Cellulitis pearls
https://www.mdedge.com/familymedicine/article/197766/dermatology/cellulitis-pearls/page/0/1?channel=234
MDedge Internal Medicine;

Mar 28th, 2019 - Concheiro and colleagues did a retrospective study of 122 cases of cellulitis and found tinea pedis in 33% of the cases. 6 Muller et al.

Pediatric Dermatology Consult - July 2018
https://www.mdedge.com/dermatology/article/168610/dermatology/pediatric-dermatology-consult-july-2018
Allison Han, Lawrence F. Eichenfield, MD

Jun 21st, 2018 - Streptococcal intertrigo is an inflammatory, superficial eruption of intertriginous skin caused by group A beta-hemolytic streptococci. Frequently misdiagnosed, streptococcal intertrigo more commonly affects infants and toddlers but is rarely repo.

Fast Five Quiz: How Much Do You Know About Cellulitis?
https://reference.staging.medscape.com/viewarticle/854910_3

Nov 29th, 2015 - Several physical examination findings may help the clinician identify the most likely pathogen and assess the severity of the infection, thereby facilitating appropriate treatment. Those findings include the following: The involved site(s) is/are ...

WCD: As MRSA situation worsens, don’t overlook strep
https://www.mdedge.com/dermatology/article/101135/infectious-diseases/wcd-mrsa-situation-worsens-dont-overlook-strep
Bruce Jancin

Jul 8th, 2015 - VANCOUVER – Here’s a key message to bear in mind in the current era of methicillin-resistant Staphylococcus aureus: “Don’t forget streptococci,” Dr. Dirk M.

see more →